| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0064 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |